A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : dCas9

Search Conditions:
Search Keyword : dCas9
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: dCas9
Appearance Frequency: 140 time(s)
Long forms: 41

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
dead Cas9
(36 times)
Molecular Biology
(6 times)
CRISPRi (6 times)
sgRNA (6 times)
DSBs (3 times)
2016 Visualization of Genomic Loci in Living Cells with a Fluorescent CRISPR/Cas9 System.
deactivated Cas9
(26 times)
Biotechnology
(7 times)
CRISPRi (9 times)
sgRNA (6 times)
CRISPR (4 times)
2016 Corynebacterium glutamicum Metabolic Engineering with CRISPR Interference (CRISPRi).
nuclease-deficient Cas9
(17 times)
Science
(5 times)
CRISPR (4 times)
sgRNA (4 times)
CRISPRa (2 times)
2015 Functional annotation of native enhancers with a Cas9-histone demethylase fusion.
nuclease-dead Cas9
(11 times)
Botany
(2 times)
CRISPR (3 times)
sgRNAs (3 times)
CRISPRi (2 times)
2013 Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system.
deactivated CRISPR-associated protein 9
(6 times)
Cell Biology
(3 times)
CRISPR (4 times)
ATFs (1 time)
CoA (1 time)
2017 RNA-Guided Activation of Pluripotency Genes in Human Fibroblasts.
nuclease-deactivated Cas9
(6 times)
Cell Biology
(2 times)
ASD (1 time)
CEH (1 time)
CRISPR-Cas9 (1 time)
2016 Current status of potential applications of repurposed Cas9 for structural and functional genomics of plants.
dead version of Cas9
(3 times)
Biochemistry
(1 time)
CRISPRi (1 time)
DSBs (1 time)
HDR (1 time)
2015 CRISPR-Cas9 Based Engineering of Actinomycetal Genomes.
defective Cas9
(2 times)
Neurology
(1 time)
CRISPR (1 time)
NDDs (1 time)
SAM (1 time)
2019 Gene activation by dCas9-CBP and the SAM system differ in target preference.
catalytically-deficient Cas9
(1 time)
Genomics
(1 time)
LTR (1 time)
msgRNAs (1 time)
2018 Comprehensive off-target analysis of dCas9-SAM-mediated HIV reactivation via long noncoding RNA and mRNA profiling.
10  CRISPR-deactivated Cas9
(1 time)
Therapeutics
(1 time)
DNMT3A (1 time)
gRNA (1 time)
hiPSC (1 time)
2018 Downregulation of SNCA Expression by Targeted Editing of DNA Methylation: A Potential Strategy for Precision Therapy in PD.
11  CRISPR-dead Cas9
(1 time)
Epigenesis, Genetic
(1 time)
--- 2020 CRISPR-mediated modification of DNA methylation pattern in the new era of cancer therapy.
12  dCas9-mediated biosensor that couples a nuclease inactivated Cas9
(1 time)
SFTS (1 time)
ST (1 time)
2018 CRISPR/dCas9-mediated biosensor for detection of tick-borne diseases.
13  deactivated Cas9 protein
(1 time)
Chemistry
(1 time)
--- 2020 Engineering of Effector Domains for Targeted DNA Methylation with Reduced Off-Target Effects.
14  deactivated CRISPR/Cas9
(1 time)
Biological Science Disciplines
(1 time)
--- 2019 Gene activation by a CRISPR-assisted trans enhancer.
15  dead CRISPR-associated 9
(1 time)
Gastroenterology
(1 time)
Cre (1 time)
CRISPR (1 time)
gRNAs (1 time)
2017 Combinatorial genetics in liver repopulation and carcinogenesis with a in vivo CRISPR activation platform.
16  dead CRISPR/Cas9
(1 time)
Biochemistry
(1 time)
--- 2019 Harnessing targeted DNA methylation and demethylation using dCas9.
17  dead form of Cas9
(1 time)
Microbiological Phenomena
(1 time)
CRISPRi (1 time)
sgRNA (1 time)
2020 A CRISPR Interference System for Efficient and Rapid Gene Knockdown in Caulobacter crescentus.
18  dead SpCas9-HF1
(1 time)
Synthetic Biology
(1 time)
gRNAs (1 time)
2019 RNA-guided piggyBac transposition in human cells.
19  dead Streptococcus pyogenes CRISPR-Cas9 enzyme
(1 time)
Molecular Biology
(1 time)
RNAPs (1 time)
sgRNA (1 time)
2019 Versatile transcription control based on reversible dCas9 binding.
20  deficient Cas9
(1 time)
Chemistry
(1 time)
--- 2019 CRISPR/Cas Applications in Myotonic Dystrophy: Expanding Opportunities.
21  developed CasID, a novel approach where the catalytically inactive Cas9
(1 time)
Molecular Biology
(1 time)
--- 2020 Locus-Specific Chromatin Proteome Revealed by Mass Spectrometry-Based CasID.
22  dinucleotides, can be performed using catalytically inactive Cas9
(1 time)
Biology
(1 time)
DSB (1 time)
NHEJ (1 time)
2019 Concurrent genome and epigenome editing by CRISPR-mediated sequence replacement.
23  direct catalytically inactive CRISPR-associated 9 nuclease
(1 time)
Biomedical Research
(1 time)
CRISPR (1 time)
gRNAs (1 time)
2013 CRISPR RNA-guided activation of endogenous human genes.
24  direct fusions of enzymatically inactivated Cas9
(1 time)
Molecular Biology
(1 time)
GBP (1 time)
2017 Site-specific recruitment of epigenetic factors with a modular CRISPR/Cas system.
25  direct inactivated Cas9
(1 time)
Synthetic Biology
(1 time)
GFP (1 time)
ISes (1 time)
2019 CRISPR-interference-based modulation of mobile genetic elements in bacteria.
26  directs catalytically inactive Cas9
(1 time)
Molecular Biology
(1 time)
CRISPRi (1 time)
2018 Robust and stable transcriptional repression in Giardia using CRISPRi.
27  disabled Cas9
(1 time)
Virology
(1 time)
gRNAs (1 time)
HIV (1 time)
KRAB (1 time)
2020 Targeted Chromatinization and Repression of HIV-1 Provirus Transcription with Repurposed CRISPR/Cas9.
28  DNA methylation by fusing inactive Cas9
(1 time)
Science
(1 time)
--- 2017 Targeted DNA methylation in vivo using an engineered dCas9-MQ1 fusion protein.
29  Dnmt3a with a catalytically inactive Cas9
(1 time)
Cell Biology
(1 time)
--- 2016 Editing DNA Methylation in the Mammalian Genome.
30  domains to either enzymatically inactive Cas9
(1 time)
Medical Informatics
(1 time)
PEs (1 time)
2021 PnB Designer: a web application to design prime and base editor guide RNAs for animals and plants.
31  knock-down method using catalytically inactive Cas9
(1 time)
Genetics
(1 time)
--- 2021 Implementation of dCas9-mediated CRISPRi in the fission yeast Schizosaccharomyces pombe.
32  nuclease-deactivated CRISPR-associated nuclease-9
(1 time)
Genetic Therapy
(1 time)
CRISPR (1 time)
2021 Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editing.
33  nuclease-deactivated mutant of the Cas9 protein
(1 time)
Biochemistry
(1 time)
CRISPR (1 time)
MB (1 time)
sgRNA (1 time)
2018 A CRISPR/molecular beacon hybrid system for live-cell genomic imaging.
34  nuclease-deactivated mutant of the CRISPR-associated protein 9
(1 time)
Molecular Biology
(1 time)
CRISPR (1 time)
FP (1 time)
sgRNA (1 time)
2020 Live-Cell Imaging of Genomic Loci Using CRISPR/Molecular Beacon Hybrid Systems.
35  nuclease-deactivated variant of CRISPR-Cas9 proteins
(1 time)
Science
(1 time)
--- 2017 Drug-tunable multidimensional synthetic gene control using inducible degron-tagged dCas9 effectors.
36  nuclease-dead Cas9 protein
(1 time)
Microbiological Phenomena
(1 time)
CRISPRi (2 times)
2019 A CRISPR Interference Platform for Efficient Genetic Repression in Candida albicans.
37  nuclease-dead Streptococcus pyogenes Cas9
(1 time)
TAD (1 time)
2017 A potent Cas9-derived gene activator for plant and mammalian cells.
38  nuclease-defective mutant of Cas9
(1 time)
Natural Science Disciplines
(1 time)
CRISPRa (1 time)
VPR (1 time)
2021 CRISPR-based transcriptional activation tool for silent genes in filamentous fungi.
39  nuclease-defective, codon-optimized allele of the Streptococcus pyogenes Cas9 protein
(1 time)
Bacteriology
(1 time)
CRISPRi (1 time)
sgRNA (1 time)
2019 A Xylose-Inducible Expression System and a CRISPR Interference Plasmid for Targeted Knockdown of Gene Expression in Clostridioides difficile.
40  nuclease-deficient Cas9 mutant
(1 time)
Therapeutics
(1 time)
cART (1 time)
sgRNAs (1 time)
2015 Potent and Targeted Activation of Latent HIV-1 Using the CRISPR/dCas9 Activator Complex.
41  nuclease-deficient CRISPR/Cas9
(1 time)
Biological Science Disciplines
(1 time)
dCas9-synR (1 time)
2017 Engineering Synthetic Signaling Pathways with Programmable dCas9-Based Chimeric Receptors.